The rising tide of biotech

EBR - European Biopharmaceutical Review

Volumn , Issue AUTUMN, 2010, Pages 92-97

  Bellott, Emile ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL PRODUCT; GENERIC DRUG; PRESCRIPTION DRUG;

BIOTECHNOLOGY; COMMERCIAL PHENOMENA; COST CONTROL; DRUG APPROVAL; DRUG INDUSTRY; DRUG MANUFACTURE; DRUG MARKETING; ECONOMIC ASPECT; HEALTH CARE; PATENT; PROFIT; SHORT SURVEY;

EID: 77958192842     PISSN: 1364369X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (9)

1. Biotech Set to Dominate Drug Industry Growth, Evaluate Pharma, 17 June 2009
2. The Burrill Report, Global Pharma Sales Steadily Growing, Despite Rise of Generics, Seeking Alpha, 26 April 2010
3. VC Outlook-Bio Conference, 9 March 2010
4. Bellott E, Global environments, Navigating the Perfect Storm, European Biopharmaceutical Review: pp28-35, 2008
5. Jack A, Big Pharma Aims for Reinvention, Financial Times Online, 12 May 2010
6. DiMasi JA, Measuring Trends in the Development of New Drugs: Time, Costs, Risks and Returns, Tufts Center for the Study of Drug Development, 19 March 2007
7. Burger L, Battle Over Biosimilar Drugs is Only For The Brave, Reuters, 2 July 2010
8. A Race to Develop Better-Performing Biopharmaceuticals, The Wall Street Journal, 10 August 2010
9. 30th Annual Canaccord-Genuity Growth Conference, Boston, 9 August 2010